Clinical Applications of Simultaneous PET/MR Imaging Using (R)-[11C]-Verapamil with Cyclosporin A: Preliminary Results on a Surrogate Marker of Drug-Resistant Epilepsy

^aFrom the Department of Neurology (J.-W.S., K.C., K.-H.J., S.-T.L., J.M., D.Y.L., S.K.L.), Comprehensive Epilepsy Center, Laboratory for Neurotherapeutics, Biomedical Research Institute
^bDepartment of Nuclear Medicine (S.A.S., Y.-S.L., J.S.L., D.S.L.)
^cDepartment of Biomedical Sciences (S.A.S., J.S.L.), Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea
^dDepartment of Neurology (J.-W.S.), CHA Bundang Medical Center, CHA University, Seongnam, Korea
^eDepartment of Molecular Medicine and Biopharmaceutical Sciences (Y.-S.L., D.S.L.), Graduate School of Convergence Science and Technology, Kyunggi, South Korea.

Please address correspondence to Sang Kun Lee, MD, PhD, Department of Neurology, Seoul National University Hospital, 101, Daehangro, Jongro-Gu, Seoul 110-744, South Korea; e-mail: sangkun2923{at}gmail.com